1/87
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Pancreas location
Abdominal organ behind stomach.
Pancreas length
15 cm.
Pancreas divisions
Head, body, tail.
Pancreatic head location
Curvature of duodenum.
Pancreatic body characteristic
Longest part.
Pancreatic tail location
Near spleen.
Main pancreatic duct
Joins common bile duct forming hepatopancreatic ampulla.
Hepatopancreatic ampulla opening
Duodenum.
Accessory pancreatic duct
Also drains into duodenum.
Exocrine pancreas definition
Secretes fluids onto epithelial surface.
Acinar cells function
Secrete digestive enzymes (proteases, amylase, lipase).
Duct cells function
Secrete bicarbonate (HCO3−).
Endocrine pancreas component
Islets of Langerhans.
Alpha cells (α) product
Glucagon.
Beta cells (β) product
Insulin.
Delta cells (δ) product
Somatostatin.
PP cells product
Pancreatic polypeptide.
Pancreatic polypeptide function
Regulates gastric secretions.
Pancreatic juice pH
~8.
Pancreatic juice components
Bicarbonate, digestive enzymes.
Proteases secretion form
Zymogens (e.g., trypsinogen).
Amylase function
Breaks down carbohydrates.
Lipase function
Breaks down fats.
Nucleases function
Break down nucleic acids.
CCK source
Duodenal enteroendocrine cells.
CCK stimulus
Chyme entering duodenum.
CCK action 1
Stimulates enzyme secretion from acinar cells.
CCK action 2
Stimulates gallbladder contraction.
CCK action 3
Relaxes hepatopancreatic sphincter.
Secretin source
Duodenal enteroendocrine cells.
Secretin stimulus
Acidic chyme.
Secretin action 1
Stimulates bicarbonate secretion.
Secretin action 2
Increases bile production.
Vagal nerve pancreatic effect
Weak gallbladder contractions.
Insulin source
Beta cells.
Insulin liver action 1
Promotes glycogenesis.
Insulin liver action 2
Inhibits glycogenolysis.
Insulin muscle action 1
Increases glucose uptake.
Insulin muscle action 2
Increases glycogen synthesis.
Insulin adipose action 1
Increases glucose uptake.
Insulin adipose action 2
Increases fat storage.
Insulin release trigger
High blood glucose.
Glucagon source
Alpha cells.
Glucagon liver action 1
Promotes glycogenolysis.
Glucagon liver action 2
Promotes gluconeogenesis.
Glucagon adipose action
Promotes lipolysis.
Glucagon release trigger
Low blood glucose.
Somatostatin function
Inhibits insulin and glucagon release.
Insulin-glucagon relationship
Counter-regulatory hormones.
Insulin feedback
Inhibits glucagon release.
Glucagon feedback
Inhibited by insulin.
Parasympathetic insulin effect
Stimulates release.
Parasympathetic neurotransmitter
Acetylcholine.
Sympathetic glucagon effect
Stimulates release.
Sympathetic neurotransmitter
Noradrenaline.
Adrenaline glucose effect
Promotes glycogenolysis.
Cortisol glucose effect 1
Promotes gluconeogenesis.
Cortisol glucose effect 2
Reduces glucose utilization.
Beta cell glucose sensor
GLUT2 transporter.
Beta cell glucose phosphorylation
Glucokinase.
Beta cell insulin secretion mechanism
ATP closes K+ channels → depolarization → Ca2+ influx.
Glucagon receptor type
GPCR.
Glucagon receptor pathway
Adenylate cyclase → cAMP → PKA.
Insulin receptor type
Receptor tyrosine kinase.
Insulin receptor action
Phosphorylates intracellular proteins.
Diabetes mellitus prevalence
2% western population.
Type 1 diabetes cause
Autoimmune beta cell destruction.
Type 1 diabetes treatment
Insulin injections.
Type 2 diabetes cause
Insulin resistance.
Type 2 diabetes treatment
Diet, exercise, medications.
Gestational diabetes characteristic
Occurs during pregnancy.
Diabetes insipidus cause
ADH deficiency or insensitivity.
Diabetes insipidus symptoms
Excessive thirst, dilute urine.
Insulin administration route
Injection (not oral).
Insulin not oral reason 1
Destroyed by stomach acid.
Insulin not oral reason 2
Large molecule, not absorbed.
Insulin treatment risks
Hypoglycemia, weight gain, neuropathy.
Hyperinsulinism cause
Pancreatic benign tumor.
Hyperinsulinism symptoms
Low blood glucose, anxiety, sweating.
Pancreatitis causes
Gallstones, alcohol, high triglycerides.
Pancreatitis symptoms
Severe inflammation and pain.
Pancreatitis mortality
100,000 deaths worldwide.
Pancreatic cancer types
Exocrine (85%), neuroendocrine.
Exocrine cancer types
Adenocarcinoma (most), acinar cell carcinoma (5%).
Adenocarcinoma location
Pancreas head.
Acinar cell carcinoma effect
Increased enzyme production.
Neuroendocrine tumor types
Functioning or non-functioning.
Pancreatic cancer prognosis
Often late diagnosis, low survival.